Advertisement

Search Results

Advertisement



Article Topics

Your search for Kevin Knopf, MD, MPH, and Charles Bennett, MD, PhD, MPP matches 1 pages

Showing 1 - 1


cost of care

The Emperor’s New Clothes: Biosimilars and Cost in Oncology

Biosimilars are biologic products similar to the parent (branded) molecule in structure and function—such as erythropoietin and filgrastim (Neupogen).1 To truly bend the cost curve, we want to see a dramatic economic savings achieved as oncology biosimilars for rituximab (Rituxan), trastuzumab...

Advertisement

Advertisement



;
Advertisement